Thursday, April 30, 2015

Stock market hammered despite upbeat data

Still another day with investors being unable to decide whether or not they want a recovery when, in spite of a slew of very positive news, the Dow still tanked big time to the tune of 195 points.  Jobless benefits reaching a 15-year low this week was just one of the many indicators that surfaced today to point to a continuing recovery.  Thus the question was also once again raised that maybe interest rates will be raised sooner rather than later.  Apple also dragged the market down after the Apple Watch was reported to be defective.  But doesn't Apple have a very long history of having bumpy intros of its new innovations only to come out smelling like a rose later?  So there was no rational reason for all the panic selling but then no one can argue that this is a rational market of late.  The panic today was a big one with volume way above average at 7.8 billion shares.

Markets | Thu Apr 30, 2015 6:02pm EDT

Stock market hammered despite upbeat data


DJ:    17,840.52  -195.01     NAS:    4,941.42  -82.22       S&P:      2,085.51  -21.34

 (Reuters) - U.S. stocks sold off on Thursday, led by a drop in the Nasdaq, as Apple shares declined and results in tech and biotech names disappointed.
Upbeat economic reports added to uncertainty about the outlook for interest rates, a day after data showed the U.S. economy slowed to a crawl in the first quarter and the Federal Reserve pointed to weakness in the labor market and other areas of the U.S. economy.
Despite the day's decline, all three major indexes posted slight gains for April.
The Nasdaq biotech index .NBI dropped 3.1 percent, led by a 4.5 percent fall in Celgene (CELG.O), which reported lower-than-expected quarterly revenue.
The decline marked a fifth day of losses for the biotech index, bringing losses in the index to 8.1 percent for the week so far. The Nasdaq fell for its fourth straight session, while the S&P tech index .SPLRCT fell 1.6 percent, the day's worst-performing sector.
Apple (AAPL.O) was down 2.7 percent at $125.15 and was the biggest drag on the Dow, S&P 500 and the Nasdaq. The company limited the availability of the Apple Watch after a key component was found to be defective, according to the Wall Street Journal.
"We didn't get a rally off of the Fed statement and that kind of set the stage for this morning," said Bucky Hellwig, senior vice president at BB&T Wealth Management in Birmingham, Alabama.
"It didn't add any clarity. That kind of tied in with not a lousy earnings season but a flattish earnings season. There's just not a compelling reason to buy."
The Dow Jones industrial average .DJI fell 195.01 points, or 1.08 percent, to 17,840.52, theS&P 500 .SPX lost 21.34 points, or 1.01 percent, to 2,085.51 and the Nasdaq Composite.IXIC dropped 82.22 points, or 1.64 percent, to 4,941.42.
For the month, the Dow was up 0.4 percent, the S&P 500 gained 0.9 percent and the Nasdaq rose 0.8 percent.
The day's data included a report showing the number of Americans filing new claims for jobless benefits tumbled to a 15-year low last week, which suggested the economy is picking up.
Among other decliners, Yelp (YELP.N) shares slumped 23.2 percent to $39.39 a day after the consumer review website operator forecast second-quarter revenue below analysts' expectations.
Baidu (BIDU.O) declined 8.5 percent to $200.28 after China's dominant Internet search engine provider posted its slowest quarterly revenue growth rate in almost seven years.
S&P 500 earnings for the first quarter now are forecast to have increased 1.1 percent from a year ago, Thomson Reuters data showed, while revenue is forecast to be down 3.2 percent.
Declining issues outnumbered advancing ones on the NYSE by 2,355 to 693; on the Nasdaq, 2,131 issues fell and 647 advanced. The benchmark S&P 500 index posted six new 52-week highs and three new lows; the Nasdaq Composite recorded 39 new highs and 91 new lows.

About 7.8 billion shares changed hands on U.S. exchanges, compared with the 6.3 billion daily average for the month to date, according to data from BATS Global Markets.

No comments:

Post a Comment